In patients with moderate-to-severe allergic rhinoconjunctivitis induced by house dust mites, subcutaneous allergen immunotherapy is effective and generally well tolerated.
Measuring visual acuity and intraocular pressure at 5 years after diagnosis, and checking for conditions such as nystagmus ...